Mariero LH, Torp M‐K, Heiestad CM, et al. Inhibiting nucleolin reduce inflammation induced by mitochondrial DNA in cardiomyocytes exposed to hypoxia and reoxygenation. Br J Pharmacol. 2019;176:4360--4372. 10.1111/bph.14830

Lars Henrik Mariero and May‐Kristin Torp shared first authorship.

What is already known {#bph14830-sec-1001}
=====================

Extracellular mitochondrial DNA is internalized through an unknown mechanism and cause injury to cardiac cells.

What this study adds {#bph14830-sec-2101}
====================

Extracellular mitochondrial DNA binds to nucleolin.Extracellular mitochondrial DNA is internalized by nucleolin, and blocking nucleolin reduces mitochondrial DNA‐induced inflammation.

What is the clinical significance {#bph14830-sec-2001}
=================================

Nucleolin might be a therapeutic target to reduce uptake of immunogenic DNA, thus decreasing inflammation.

DAMP

:   damage‐associated (or danger‐associated) molecular pattern

HDAC2

:   histone deacetylase 2

mtDNA

:   mitochondrial DNA

Ncl

:   nucleolin

NCX

:   sodium--calcium exchanger

nDNA

:   nuclear DNA

NLR

:   nucleotide‐binding oligomerization domain (NOD)‐like receptor

qPCR

:   quantitative real‐time PCR

Rpl 32

:   60S ribosomal protein L32

SAP

:   stable angina pectoris

STEMI

:   ST elevation myocardial infarction

1. INTRODUCTION {#bph14830-sec-0007}
===============

After myocardial infarction, debris from necrotic cardiac cells and extracellular matrix activates the innate immune system (Frangogiannis, [2014](#bph14830-bib-0017){ref-type="ref"}). Endogenous molecules that trigger the innate immune system are called damage‐associated molecular patterns (DAMPs; Seong & Matzinger, [2004](#bph14830-bib-0043){ref-type="ref"}). DAMPs stimulate receptors of the innate immune system including <https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=317> and <https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=316>; Arslan, de Kleijn, & Pasterkamp, [2011](#bph14830-bib-0005){ref-type="ref"}). DAMPs released from post‐ischaemic cardiomyocytes may include high‐mobility group box 1 (Andrassy et al., [2008](#bph14830-bib-0004){ref-type="ref"}; Ding et al., [2013](#bph14830-bib-0013){ref-type="ref"}), heat‐shock proteins (Dybdahl et al., [2005](#bph14830-bib-0015){ref-type="ref"}; Gupta & Knowlton, [2007](#bph14830-bib-0020){ref-type="ref"}; Tian et al., [2013](#bph14830-bib-0048){ref-type="ref"}; Zou et al., [2008](#bph14830-bib-0054){ref-type="ref"}), ATP (la Sala et al., [2003](#bph14830-bib-0042){ref-type="ref"}), uric acid (Shi, Evans, & Rock, [2003](#bph14830-bib-0044){ref-type="ref"}), and mitochondrial DNA (mtDNA; Nakayama & Otsu, [2018](#bph14830-bib-0034){ref-type="ref"}).

Mitochondria occupy 30% of the volume of the human heart (Barth, Stammler, Speiser, & Schaper, [1992](#bph14830-bib-0006){ref-type="ref"}), and we have shown that mtDNA is released into the circulation from the heart of patients with ST elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (Bliksoen et al., [2012](#bph14830-bib-0007){ref-type="ref"}). mtDNA has been suggested to resemble bacterial DNA which contains pro‐inflammatory, unmethylated CpG motifs (Collins, Hajizadeh, Holme, Jonsson, & Tarkowski, [2004](#bph14830-bib-0011){ref-type="ref"}; Pollack, Kasir, Shemer, Metzger, & Szyf, [1984](#bph14830-bib-0038){ref-type="ref"}). mtDNA has been shown to induce sterile inflammation through the intracellular <https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1759> receptor in human neutrophils (Zhang et al., [2010](#bph14830-bib-0053){ref-type="ref"}). The mitochondria have a central role in reperfusion injury in general (Kloner et al., [2017](#bph14830-bib-0032){ref-type="ref"}). Moreover, in pressure‐overloaded mice, DNase activity or ablation of TLR9 disrupts the deleterious inflammatory response to mtDNA and improves survival after transaortic constriction (Oka et al., [2012](#bph14830-bib-0037){ref-type="ref"}). mtDNA triggers NF‐κB activation possibly by a TLR9‐dependent mechanism in an in vivo mouse model and in HEK293 cells (Bliksoen et al., [2016](#bph14830-bib-0008){ref-type="ref"}). Still, the mechanism for mtDNA to activate an immune response in primary cardiac cells, and how mtDNA may be internalized, remains unknown.

Many DAMPs are recognized by intracellular receptors (Nunez, [2011](#bph14830-bib-0035){ref-type="ref"}), and though ligand--receptor interaction is obligate for host recognition and response, the mechanisms of DAMP internalization are poorly understood. TLR9 is an intracellular receptor located in the endosome (Hemmi et al., [2000](#bph14830-bib-0023){ref-type="ref"}) and inhibiting the uptake of DNA ligands of TLR9 is a possible mechanism for modulating TLR9‐mediated immune responses. Nucleolin is a multifunctional protein abundant in the nucleolus of eukaryotic cells (Tajrishi, Tuteja, & Tuteja, [2011](#bph14830-bib-0046){ref-type="ref"}). It is subject to post‐translational modification and regulation and contains four DNA‐binding sites as well as numerous glycosylation and phosphorylation sites (Cong, Das, & Bouvet, [2011](#bph14830-bib-0012){ref-type="ref"}). Nucleolin is implicated in ribosome maturation, RNA and DNA metabolism, and shuttling of pre‐RNAs from the nucleus to the cytoplasm (Medina, Fernando, Isabel Manzano, Manrique, & Herranz, [2010](#bph14830-bib-0033){ref-type="ref"}; Tajrishi et al., [2011](#bph14830-bib-0046){ref-type="ref"}). The function of nucleolin in the heart is poorly understood. In a study of 71 explanted human hearts, nucleolin mRNA and protein were increased in both ischaemic and dilated cardiomyopathy compared to control hearts, and nucleolin expression correlated with left‐ventricular end‐diastolic diameter (Rosello‐Lleti et al., [2012](#bph14830-bib-0040){ref-type="ref"}). Mice overexpressing nucleolin had reduced infarct size in an in vivo model of 30 minutes ischaemia followed by 24hours reperfusion (Jiang et al., [2013](#bph14830-bib-0027){ref-type="ref"}). Nucleolin has been implicated in ischaemic preconditioning of the heart (Jiang et al., [2014](#bph14830-bib-0026){ref-type="ref"}), and heat‐shock proteins may mediate the protective effects of nucleolin (Jiang et al., [2010](#bph14830-bib-0028){ref-type="ref"}; Jiang et al., [2013](#bph14830-bib-0027){ref-type="ref"}; Jiang et al., [2014](#bph14830-bib-0026){ref-type="ref"}). Cell‐surface nucleolin has been implicated in internalization of human immunodeficiency virus in T lymphocytes (Said et al., [2002](#bph14830-bib-0041){ref-type="ref"}), uptake of DNA nanoparticles (Chen, Kube, Cooper, & Davis, [2008](#bph14830-bib-0010){ref-type="ref"}), and as a target for a 26 base pair anticancer DNA aptamer (Soundararajan et al., [2009](#bph14830-bib-0045){ref-type="ref"}).

We hypothesized that extracellular DNA, including mtDNA, triggers innate immunity signalling in primary cardiac cells exposed to hypoxia/reoxygenation (H/R) via TLR9 and that nucleolin on the cell surface is responsible for internalizing extracellular DNA in primary cardiac cells.

2. METHODS {#bph14830-sec-0008}
==========

2.1. Experimental animals {#bph14830-sec-0009}
-------------------------

All animal care and experimental procedures were approved and conducted in accordance with the Norwegian Animal Health Authority (FOTS application number 7710). Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., [2010](#bph14830-bib-0031){ref-type="ref"}) and with the recommendations made by the *British Journal of Pharmacology*. C57BL/6 male mice (NOVA‐SCB, Nittedal, Norway) weighing 26 ± 0.4 g (age 10--16 weeks, *n* = 75 for the entire study) with conventional microbiological status were kept in a controlled environment (12:12‐hr light/dark period; 23°C; 55--60% humidity; and free access to water and chow \[RM3; NOVA‐SCB\]). Animals were acclimatized for at least 7 days before the experiments. Mice were anaesthetized by intraperitoneal injection of sodium pentobarbital (50 mg·kg^−1^) and 500 IU heparin (Leo Pharma A/S, Denmark) and killed by cervical dislocation for collection of the liver (to isolate mtDNA) and the heart for subsequent perfusion.

2.2. Isolation of cardiomyocytes and cardiac fibroblasts {#bph14830-sec-0010}
--------------------------------------------------------

Adult murine cardiomyocytes were isolated with a modified method originally described by O\'Connell, Rodrigo, and Simpson ([2007](#bph14830-bib-0036){ref-type="ref"}). In short, hearts were cannulated and retrogradely perfused at 4 ml·min^−1^ with perfusion buffer (containing in mM: NaCl 120.4; KCl 14.7; KH~2~PO~4~ 0.6, Na~2~HPO~4~ 0.6; MgSO~4~ 1.2; Na‐HEPES 10.0; glucose 5.5; NaHCO~3~ 4.6; taurine 30.0; BDM 10.0) before switching to collagenase II digestion (\#4177, batch 44C14813, activity 385 U·mg^−1^, Worthington, Lakewood, NJ, USA), low‐speed centrifugation (20 × *g*), and gradual calcium reintroduction. Isolated cardiomyocytes were resuspended in plating medium containing MEM (minimal essential medium) with Hanks BSS (balanced salt solution; \#M5775), 10% FBS (\#SH30073.03, lot \#AVA60491, Thermo Fisher Scientific, MA, USA), 10‐mM BDM (2,3‐butanedione monoxime, \#B0753), 100 U·ml^−1^ penicillin--streptomycin (\#P4333), and 2‐mM [l]{.smallcaps}‐glutamine (\#G7513) and left to attach on laminin‐coated plates (1 μg·cm^−2^, \# 354232, BD Biosciences, East Rutherford, NJ, USA) for 1--2 hr at 37°C and 2% CO~2~. After plating medium was removed, short‐term culture medium was added (MEM with the same antibiotic and [l]{.smallcaps}‐glutamine supplements as plating medium, but with 0.10% fatty‐acid free BSA \[\#A8806\] instead of FBS and 1‐mM BDM).

Cardiac fibroblasts were isolated from the supernatant of the first low‐speed centrifugation by re‐centrifuging twice for 5 min at 700*× g*. The cells were resuspended in fibroblast medium containing MEM with Hanks BSS, 10% FBS (\#10270‐106, lot \#41Q3723K, Life Technologies), and 100 U·ml^−1^ penicillin--streptomycin and 2‐mM [l]{.smallcaps}‐glutamin and seeded in uncoated flasks. The cardiac fibroblasts were kept at 37°C and 5% CO~2~ and passaged three times (1--2 weeks) before they were used in experiments and are referred to as cultured cardiac fibroblasts (C‐CF). For some applications, freshly isolated cardiac fibroblasts were used, referred to as CF. The purity of the cell fractions was evaluated by qPCR (Figure [S1](#bph14830-supitem-0001){ref-type="supplementary-material"}). PCR primer sequences are listed in Table [S1](#bph14830-supitem-0001){ref-type="supplementary-material"}. Cells were confirmed mycoplasma‐free.

For the cytokine expression in cardiomyocytes, two series of experiments were performed at two different times. In the first series (Figure [1](#bph14830-fig-0001){ref-type="fig"}a--c, *n* = 6), primary cardiomyocytes were seeded into six parallels, while in the second series (Figure [1](#bph14830-fig-0001){ref-type="fig"}d--f, *n* = 12), five parallels were used.

![mtDNA‐induced inflammation in cardiomyocytes during hypoxia/reoxygenation (H/R) is reduced by blocking nucleolin. Quantitative real‐time PCR on isolated adult C57BL/6 murine cardiomyocytes exposed to 40 min of non‐lethal glucose‐free hypoxia (\<0.5% O~2~) followed by 2 hr of reoxygenation (Ctr. H/R) or time‐matched normoxic conditions with medium change (Ctr Norm.) was performed. Cells were exposed to murine mitochondrial DNA‐enriched fraction (20 μg·ml^−1^ total, \>5‐μg mtDNA, \<15 μg·ml^−1^ nDNA) or nuclear DNA (nDNA, 20 μg·ml^−1^, nDNA H/R) in normal medium (mtDNA norm and nDNA norm) or in combination with H/R (mtDNA H/R and nDNA H/R). Two independent series of experiments were conducted; (a--c) *n* = 6 and (d--f) *n* = 12. The data shows relative gene (2^−ΔΔCt^) expression of (a) IL‐1β, (b) IL‐6, or (c) TNF‐α. (d) and (e) shows expression of IL‐1β and TNF‐α exposed to mtDNA‐H/R and blockade of nucleolin with either midkine (200 nM) or the aptamer AS1411 (10 μg·ml^−1^). Data are relative to the expression of the housekeeping gene Rpl32 and normalized to (a--c) normoxic control cells or (d--f) hypoxic cells. (f) [elisa]{.smallcaps} of media at the end of the reoxygenation protocol shows release of IL‐6 from mouse cardiomyocytes. Data are presented as mean ± *SEM*. In a‐c, \**P* \< .05, significantly different as indicated; Kruskal--Wallis test with a Dunn post‐test. In d‐f, \**P* \< .05, significantly different as indicated; Freidman ANOVA with Dunn post‐test](BPH-176-4360-g001){#bph14830-fig-0001}

2.3. Isolation of mitochondrial and nuclear DNA {#bph14830-sec-0011}
-----------------------------------------------

C57BL/6 mice were killed by cervical dislocation, and livers were quickly extracted and washed in ice‐cold sterile PBS. Mitochondria were isolated using a 2‐mL Kontes Dounce tissue grinder and the Mitochondria Isolation Kit for Tissue (\#89801, Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer\'s instructions, by initial centrifugation at 700× *g* and 3,000× *g* and with two additional washing steps with buffer C. The pellet after the first centrifugation at 700× *g* was used to isolate nuclear DNA (nDNA). DNA was isolated using spin columns (\#69506, Qiagen DNeasy Blood & Tissue, Venlo, Netherlands) according to the manufacturer\'s instructions. mtDNA was extracted from isolated mitochondria and nDNA from crude nuclear extracts, both from mouse liver tissue. DNA was fragmented on ice using a 30‐kHz/50‐W ultrasonic sonicator (\#UPH50, Hielscher Ultrasonics, Teltow, Germany) with a 0.5‐mm head at 14 μm for 2 × 30 s. Fragmentation after ultrasonification was visualized on a 1% agarose gel with SYBR safe DNA dye (\#33012, Life Technologies, Carlsbad, CA, USA), and the relative abundance of mtDNA and nDNA was determined by qPCR (Figure [S2](#bph14830-supitem-0001){ref-type="supplementary-material"}). Calculations and estimation of the absolute concentrations of mtDNA and nDNA in the two fractions are described in detail in the [Supporting Information](#bph14830-supitem-0001){ref-type="supplementary-material"}. In brief, calculations from the qPCR reaction indicate that the mitochondrial fraction contains at least 5 μg·ml^−1^ mtDNA and 15 μg·ml^−1^ nDNA while the nuclear fraction only contains nDNA. Inspection of the agarose gels (Figure [S2](#bph14830-supitem-0001){ref-type="supplementary-material"}) indicated breaks in the non‐sonicated mtDNA, which could underestimate the actual amount of mtDNA measured by qPCR. As nDNA contained no mtDNA, the differences found in the response are likely to be due to the presence or not of mtDNA. In the discussion, we therefore refer to mtDNA and nDNA, while in the figures, we describe the doses as mtDNA‐enriched extracellular DNA and nDNA.

2.4. Hypoxia/reoxygenation (H/R) model {#bph14830-sec-0012}
--------------------------------------

The oxygen concentration in culture medium was measured with a galvanometric oxygen electrode, (Oxi 323, WTW, Weilheim, Germany, Figure [S3A](#bph14830-supitem-0001){ref-type="supplementary-material"}). Glucose‐free DMEM (\#D5030‐1L) was left in \<0.5% O~2~, 2.0% CO~2~ overnight in a hypoxia chamber (\#856‐HYPO, Plas Labs, Lansing, MI, USA) prior to experiments. Cells were brought into the chamber, washed once with hypoxic medium (to wash out oxygen on tissue culture plate and medium, Figure [S3B](#bph14830-supitem-0001){ref-type="supplementary-material"}), and exposed to hypoxic conditions for 40 min before reoxygenation in normal glucose‐containing medium in a normoxic incubator. Control cells followed the same protocol as cells exposed to H/R, but without hypoxia. Cell death was assessed by LDH release (Cytotoxicity Detection Kit, Roche, Penzberg, Germany). The nucleolin inhibitor midkine (\#SRP3301) was dissolved in PBS and 0.1% BSA to a stock solution (74.6 μM) and dissolved to a final concentration of 200 nM. The aptamer AS1411 (Invitrogen, sequence in Table [S2](#bph14830-supitem-0001){ref-type="supplementary-material"}) was dissolved in endotoxin‐free water and refolded according to the manufactures protocol at 65°C for 15 min (stock 1 mg·ml^−1^). Fresh aliquots were prepared at the day of the experiments. For each media change, new mtDNA and blockers were added to the respective groups. The vehicle control groups received similar media change. As there are some day‐to‐day variability in the response from isolated cardiomyocytes and the HEK293 cells, the data are normalized to the control groups.

2.5. Assessing TLR9‐dependent NF‐κB activity and cytokine expression in HEK293 cells {#bph14830-sec-0013}
------------------------------------------------------------------------------------

TLR9‐dependent NF‐κB activity was assessed using commercially available HEK293 cells co‐transfected with mouse TLR9 and an inducible secreted embryonic alkaline phosphatase (SEAP) reporter coupled to NF‐κB (HEK‐Blue mTLR9, RRID:CVCL_IM93, Invivogen, Toulouse, France). Cells without TLR9 (HEK‐Blue Null1) served as controls, and all cells were cultured according to instructions of the manufacturer. NF‐κB reporter activity was quantified with spectrophotometer. In H/R experiments, the hypoxia protocol was as previously described with reoxygenation for 6--12 hr. The cells were exposed to treatments, including CpG A (20 μg·ml^−1^, ODN2216, Invivogen), CpG B (20 μg·ml^−1^, ODN1668, Invivogen), inhibitory CpG (CpGi, 20 μg·ml^−1^, ODN2088), <https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5535> (\#C6628, 100 ng·ml^−1^), or the nucleolin inhibitor midkine.

To investigate endogenous cytokine expression, HEK293‐Blue Null1 cells were plated at a density of 70,000 HEK293 cells in each well in a 12‐well plate and left overnight. Cells were exposed to 20 μg·ml^−1^ mtDNA or 20 μg·ml^−1^ nDNA overnight (approximately 20 hr). Cells were washes twice with 1X PBS before lysed in RLT buffer. AE buffer was used as vehicle control. RNA, cDNA, and qPCR were done in same way as previous with cardiomyocytes (primer sequences in Table [S3](#bph14830-supitem-0001){ref-type="supplementary-material"}).

2.6. Transfection of HEK293 cells {#bph14830-sec-0014}
---------------------------------

Transfection with Lipofectamine® 2000 Transfection Reagent (\#11668027, Thermo Fisher Scientific, Massachusetts, USA) was performed according to manufacturers\' protocol. In short, cells were seeded at a density of 2.8 × 10^4^ cells·cm^−2^ 1 day prior to transfection. At the day of transfection, cells were washed twice and kept in antibiotic‐free medium. DNA (0.5 μg·cm^−2^; GFP‐nucleolin plasmid \[\#28176, Addgene, Massachusetts, USA\]) and lipofectamine were diluted in Opti‐MEM (\#31985070, Thermo Fisher Scientific, Massachusetts, USA) before the two solutions were combined and added to the cells. After 4‐hr incubation (37°C, 5% CO~2~), DNA‐lipofectamine complexes were exchanged for normal cell medium; 48 hr post transfection, efficiency was evaluated visually, based on GFP‐positive cells, with a Nikon Eclipse TS100 microscope (Nikon, Tokyo, Japan) with an Omron H7ET Nikon illumination system (Nikon, Tokyo, Japan), and pictures taken with Digital Sight DS‐LE (Nikon, Tokyo, Japan). Overexpression of nucleolin was investigated with western blotting and with confocal microscopy.

2.7. Protein expression of recombinant nucleolin and MST binding assay {#bph14830-sec-0015}
----------------------------------------------------------------------

### 2.7.1. Protein expression and purification {#bph14830-sec-0016}

A pET28b plasmid containing a codon optimized nucleotide sequence of human nucleolin (residues 300--650, inserted between the NdeI and BamHI restriction sites) was transformed into *Escherichia coli* BL21‐CodonPlus (DE3)‐RIPL competent cells by heat pulse (Agilent). The transformed cells were grown to an OD~600~ of 0.5 at 37°C in 2 L of LB medium supplemented with kanamycin before the temperature was lowered to 18°C, and the culture was induced with 0.25‐mM isopropyl β‐D‐thiogalactoside and left overnight for expression of the N‐terminal His‐tagged nucleolin. The cell culture was centrifuged at 6,500× *g* for 20 min, and the cell pellet was dissolved in 60 ml of sonication buffer (300‐mM NaCl, 10‐mM imidazole, 10‐mM TRIS pH 8, 10‐mM β‐mercaptoethanol; buffer 1). Cells were lysed by 3 × 30 s sonication, and a cell‐free extract was prepared by centrifugation at 27,000× *g* for 20 min. The protein was purified using cobalt and nickel ion‐metal affinity chromatography (IMAC) with Ni‐NTA agarose and buffer 1 supplemented with 50‐mM imidazole. Fractions rich in nucleolin were pooled and dialysed against PBS.

### 2.7.2. Microscale thermophoresis (MST) {#bph14830-sec-0017}

MST was used to study the interaction of nucleolin with mitochondrial (mt) and nuclear (n) DNA. The purified nucleolin was labelled with the NT‐647 RED‐tris‐NTA dye for His‐tagged proteins following the recommended labelling protocol (Nanotemper Technologies). In brief, 100 μl of 200‐nM protein was mixed with 100 μl of 100‐nM dye and incubated at room temperature for 30 min. The labelled protein was added to a 1:1 dilution series of the DNA in buffer X to a final concentration of 50 nM. The mtDNA concentration was diluted 16 times relative to the nDNA (in mg·ml^−1^). The 16 different samples were left for a few minutes before loaded into premium coated NT.115 MST capillaries (Nanotemper). Fluorescence profiles were measured at 25°C in a Monolith NT.115 instrument using the red channel. Data were collected at 60% MST power and 80% excitation power, and the fluorescence signals during the thermophoresis were monitored for 30 s. The changes in fluorescence (Δ*F* ~norm~) due to thermophoresis were measured as the signal difference between time points 0 and 5 s. Data were normalized and plotted as a function of the ligand concentration, and a binding curve was fitted to the average of three independent dilution series of each form of the DNA. The concentration of the DNA was calculated using an average molecular mass of DNA corresponding to 300 base pairs, as taken from the agarose gel analysis of the sonicated DNA (Figure S2C).

2.8. Quantification of CpG and dextran uptake in cardiac cells {#bph14830-sec-0018}
--------------------------------------------------------------

Primary cardiomyocytes or cultured cardiac fibroblasts were seeded on eight‐well chamber slides (\#154534, LabTek, Thermo Scientific) and incubated with 20 μg·ml^−1^ FITC‐labelled CpG C (ODN2395f, Invivogen) for \~16 hr before staining with 0.7 μg·ml^−1^ Hoechst 33342 (Life Technologies) and mounting (gelatin \[166 mg·ml^−1^\] in water and 50% glycerol). Automated image acquisition and analysis was performed using an Olympus Scan^R^ fluorescent microscope. In brief, the microscope acquires a predefined number of images at the same place in each well (25 images per well in this experiment), assuring objectivity for the acquisition. The software allows detailed resolution and objectivity as the software only allows equal thresholds for all scanned images. For cardiomyocytes, the average maximum fluorescence was used as a measure for CpG and dextran (D22910, 10,000 MW, molecular probes, Invitrogen) uptake. For evaluation of endocytosis, the cardiomyocytes were incubated overnight with dextran with or without cytochalasin D (10 or 50 μM) or dynasore (10 or 25 μM). For cardiac fibroblasts, CpG was analysed, and the average fluorescence per spot was used. The analysis settings were different because the number of spots was lower in the cardiomyocytes and not all cells contained fluorescent signal. Though the uptake of CpG by different cell types could not be appropriately analysed by the same parameters, equal automated settings were applied within each cell type. Cardiomyocytes or cardiac fibroblasts were treated without CpG, with CpG or with CpG and 200‐nM midkine or midkine alone. To confirm that the signals were intracellular, confocal microscopy was performed using a Zeiss LSM700 or 710.

2.9. Gene expression analysis {#bph14830-sec-0019}
-----------------------------

At the end of experiments, cells were washed once with PBS, lysed with 350‐μl RLT buffer supplemented with 1% β‐mercaptoethanol, and snap‐frozen in liquid nitrogen. Cells were mechanically disrupted in a beadmill (FastPrep FP120, MP Biomedicals, Santa Ana, CA, USA), and RNA was extracted using RNeasy columns and treated with RNAse‐free DNAse (both Qiagen). cDNA was reverse transcribed from 100‐ng RNA in 20 μl using qScript cDNA SuperMix (\#95048, Quanta Biosciences, Gaithersburg, MD, USA) according to instructions of the manufacturer. Minus reverse transcriptase control was included. qPCR was performed using SYBR Green (\#4368706, Life Technologies) for nucleolin (Ncl), <https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4974>, <https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4998>, <https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5074>, and Rpl32 as endogenous control on a 7900HT qPCR machine (Applied Biosystems). Primer efficiency was measured for each qPCR reaction using a standard curve on each individual plate. All reactions were normalized according to ΔΔC~q~ method to a reference gene (Rpl32 for cardiomyocytes and GAPDH for HEK293 cells).

2.10. Subcellular protein fractionation {#bph14830-sec-0020}
---------------------------------------

Subcellular protein fractionation was performed using the Compartment Protein Extraction Kit (\#2145, Merck Millipore, Billerica, MA, USA) according to instructions of the manufacturer with an additional 700× *g* centrifugation step after cell lysis to reduce nuclear carry‐over to the membrane fraction.

2.11. Immunoblotting {#bph14830-sec-0021}
--------------------

The immuno‐related procedures used comply with the recommendations made by the *British Journal of Pharmacology*. Protein expression of nucleolin in cardiomyocytes and cardiac fibroblasts and in different cardiomyocyte compartments as well as the purity of subcellular fractions were investigated by immunoblotting. In brief, 2.5‐μg protein per lane was separated on gradient SDS gels, transferred to nitrocellulose membranes, and imaged with autoradiography using X‐ray film with enhanced chemiluminescence. Reversible Ponceau staining was used as a loading control. For additional information, see Supporting Information.

2.12. ELISA {#bph14830-sec-0022}
-----------

[elisa]{.smallcaps} kits were purchased from R&D systems (R&D Systems, Inc., Minneapolis, USA), and the protocol was conducted according to the manufacturer. In brief, capture antibodies were diluted in PBS and added to high‐binding 96‐well plates 1 day in advance of the experiment. Plates were blocked with reagent diluent (1% BSA in PBS) and washed with washing buffer (0.05% Tween 20 in PBS). Substrate solution was purchased from Life Technologies (TMB Single solution, Thermo Fisher Scientific Inc.), and H~2~SO~4~ was used as stop solution. Absorbance was measured at 450 and 570 nm with BioTek PowerWave XS (BioTek, Vermont, USA).

2.13. Data and statistical analysis {#bph14830-sec-0023}
-----------------------------------

The data and statistical analysis comply with the recommendations of the *British Journal of Pharmacology* on experimental design and analysis in pharmacology. Unless otherwise stated, data are presented as mean ± *SEM*. For paired multigroup comparisons, a Freidman ANOVA with Dunn post‐test was used. For non‐paired analysis, a Kruskal--Wallis with a Dunn post‐test was used. For NF‐κB activity in mtDNA/nDNA‐treated reporter cells, a Student\'s *t* test was used. Graphpad (RRID:SCR_000306) 6.05 was used for all statistical analyses (La Jolla, CA, USA), and *P* \< 0.05 was considered statistically significant.

2.14. Materials {#bph14830-sec-1023}
---------------

Unless otherwise stated, all compounds and reagents were purchased from Sigma‐Aldrich (St. Louis, MO, USA).

2.15. Nomenclature of targets and ligands {#bph14830-sec-0024}
-----------------------------------------

Key protein targets and ligands in this article are hyperlinked to corresponding entries in <http://www.guidetopharmacology.org>, the common portal for data from the IUPHAR/BPS Guide to PHARMACOLOGY (Harding et al., [2018](#bph14830-bib-0022){ref-type="ref"}), and are permanently archived in the Concise Guide to PHARMACOLOGY 2017/18 (Alexander, Fabbro et al., [2017a](#bph14830-bib-0001){ref-type="ref"}, [b](#bph14830-bib-0002){ref-type="ref"}; Alexander, Kelly, et al., [2017](#bph14830-bib-0003){ref-type="ref"}).

3. RESULTS {#bph14830-sec-0025}
==========

3.1. Blocking nucleolin reduce mtDNA‐induced inflammation after hypoxia/reoxygenation in cardiomyocytes {#bph14830-sec-0026}
-------------------------------------------------------------------------------------------------------

In cardiomyocytes exposed to normoxic conditions, neither mtDNA nor nDNA induced pro‐inflammatory genes downstream of NF‐κB (Figure [1](#bph14830-fig-0001){ref-type="fig"}a--c). When cardiomyocytes were exposed to non‐lethal H/R, mtDNA‐induced expression of IL‐1β and TNF‐α, but this effect was reduced when nucleolin was inhibited (Figure [1](#bph14830-fig-0001){ref-type="fig"}d,e). nDNA did not induce any IL‐1β and TNF‐α after H/R (Figure [1](#bph14830-fig-0001){ref-type="fig"}a--c). The aptamer AS1411 also significantly reduced IL‐6 release from cardiomyocytes exposed to H/R (Figure [1](#bph14830-fig-0001){ref-type="fig"}f). Neither midkine nor AS1411 alone affected IL‐1β and TNF‐α expression in adult mice cardiomyocytes (Figure [S4E,F](#bph14830-supitem-0001){ref-type="supplementary-material"}). The present model of H/R did not induce cell death (Figure [S4A,B](#bph14830-supitem-0001){ref-type="supplementary-material"}), but longer duration of hypoxia yielded cell death (Figure [S4C](#bph14830-supitem-0001){ref-type="supplementary-material"}). H/R alone did not increase expression of inflammatory genes in cardiomyocytes (Figure [S4D](#bph14830-supitem-0001){ref-type="supplementary-material"}). In control experiments, glucose‐free DMEM was supplemented with glucose, and there was no effect on viability of cardiomyocytes as compared to standard medium.

3.2. Hypoxia/reoxygenation induces TLR9‐dependent NF‐κB activity in HEK293 reporter cells {#bph14830-sec-0027}
-----------------------------------------------------------------------------------------

In HEK293 reporter cells, H/R‐induced NF‐κB activity after \~6--7 hr of reoxygenation (Figure [S5A,B,D,E](#bph14830-supitem-0001){ref-type="supplementary-material"}), and NF‐κB activity was increased at 8 hr (Figure [2](#bph14830-fig-0002){ref-type="fig"}a). In normoxia, both CpG A and CpG B induced NF‐κB activity over time‐matched control (Figure [2](#bph14830-fig-0002){ref-type="fig"}a). In normoxia, CpG B induced NF‐κB activity more than three times higher than CpG A (Figure [2](#bph14830-fig-0002){ref-type="fig"}a).

![Extracellular DNA induces NF‐κB activity in HEK293 cells. (a) HEK293 NF‐κB reporter cells overexpressing murine TLR9 were exposed to 40 min of hypoxia with 8‐hr reoxygenation (H/R) in combination with either control, 20 μg·ml^−1^ CpG A or CpG B. (b) NF‐κB activity in HEK293 cells exposed to CpG B and inhibitory CpG (CpGi, ODN 2088, 20 μg·ml^−1^), chloroquine (Clq, 100 ng·ml^−1^) or midkine (Mid, 200 nM) during 40 min of hypoxia and 6 hr of reoxygenation. (c) HEK293 cells exposed to 40 min of hypoxia and reoxygenation for 12 hr (H/R) and combinations of CpG A and CpGi or chloroquine. (d) NF‐κB activity after 40 min of hypoxia and 6 hr of reoxygenation (H/R) and 20 μg·ml^−1^ mitochondrial DNA (mtDNA enriched \<5‐μg mtDNA, \>15 μg·ml^−1^ nDNA mtDNA) or nuclear DNA (nDNA). The data shown are means ± *SEM* (*n* = 5). \**P* \< .05, significantly different as indicated; \#*P* \< .05; significantly different from control, §*P* \< .05, significantly different from nDNA. In a‐c, one‐way ANOVA with Tukey post test wa used; in d, Student\'s *t* test was used](BPH-176-4360-g002){#bph14830-fig-0002}

CpG A and CpG B stimulation acted in concert with H/R to more than double the NF‐κB activity compared to H/R alone (Figure [2](#bph14830-fig-0002){ref-type="fig"}a). TLR9 dependence was confirmed with the use of a TLR9 null cell line with the same NF‐κB reporter system (Figure [S5A--C](#bph14830-supitem-0001){ref-type="supplementary-material"}). In hypoxia, the effect of CpG B was inhibited by CpGi or chloroquine (Figure [2](#bph14830-fig-0002){ref-type="fig"}b). Furthermore, CpGi or chloroquine also inhibited the synergistic effect of CpG A and H/R (Figure [2](#bph14830-fig-0002){ref-type="fig"}c). The temporal effects of CpG A inhibition in H/R by CpGi and chloroquine are shown in Figure [S5F,G](#bph14830-supitem-0001){ref-type="supplementary-material"}.

mtDNA, but not nDNA, stimulated NF‐κB activity in normoxic HEK293 cells overexpressing TLR9, but there was no synergistic effect on NF‐κB activity between DNA ligands and H/R (Figure [2](#bph14830-fig-0002){ref-type="fig"}d). In HEK293 null cells, mtDNA but not nDNA increased expression of IL‐6 (Figure [S6A](#bph14830-supitem-0001){ref-type="supplementary-material"}). Extracellular DNA did not increase expression of TNFα in HEK293 cells (Figure [S6B](#bph14830-supitem-0001){ref-type="supplementary-material"}).

Attempts to overexpress nucleolin in HEK293 cells overexpressing TLR9 were not successful as these cells did not survive the procedure, although the TLR9 null cells survived and displayed high expression of nucleolin (Figure [3](#bph14830-fig-0003){ref-type="fig"}b).

![Nucleolin is expressed in cardiomyocyte membranes. mRNA isolated from six C57BL/6 mice, whole hearts (Heart), cardiomyocytes (CM), freshly isolated cardiac fibroblasts (CF), and cultured cardiac fibroblasts after three passages (C‐CF). (a) Relative quantification of nucleolin normalized to Rpl32 and calibrated to whole heart (*n* = 6). (b) Immunoblotting against nucleolin in cardiomyocytes and cardiac fibroblasts showed bands at 110 kDa (top black arrow) and a smaller band at 76 kDa (grey arrow). Transfecting HEK293 cells with nucleolin displayed a band at 136 kDa (HEK^n^ 110 kDa nucleolin +26.9 kDa GFP tag, black arrow) in addition to the constituent HEK293 nucleolin (HEK^0^; 110 kDa, black arrow). On top of each blot is the corresponding area with Ponceau staining as loading control. (c) The 76‐kDa band in subcellular protein fractions from cardiac myocytes and presence of the membrane marker NCX (136 kDa). Data from the different fractions are found in Figure [S8](#bph14830-supitem-0001){ref-type="supplementary-material"}. (d) Representative confocal micrographs of nucleolin immunocytochemistry using non‐permeabilized, fixed cardiomyocytes. A striated staining pattern was seen (panel (d), left, magnification in middle) while the signal was absent in cells only stained with secondary antibody and Hoechst (panel (d), right). Data represents mean ± *SEM*. \**P* \< .05, significantly different as indicated; one‐way ANOVA and Tukey multiple comparisons test](BPH-176-4360-g003){#bph14830-fig-0003}

3.3. CpG uptake is not mediated by endocytosis in cardiomyocytes {#bph14830-sec-0028}
----------------------------------------------------------------

We hypothesized that a DNA uptake mechanism would be sequence and structure independent and investigated the possible role of endocytosis. Using fluorescence‐labelled dextran, we established a model of inhibiting endocytosis by cytochalasin D or dynasore in primary mouse cardiomyocytes (Figure [S7A,B](#bph14830-supitem-0001){ref-type="supplementary-material"}). There was no effect on the uptake of fluorescent CpG in cardiomyocytes treated with 10‐ or 50‐μM cytochalasin D (Figure, [S7D](#bph14830-supitem-0001){ref-type="supplementary-material"}).

3.4. Nucleolin is expressed in cardiomyocyte membranes {#bph14830-sec-0029}
------------------------------------------------------

Nucleolin mRNA is abundant in the mouse heart, with lower Ct values in hearts and cardiomyocytes compared to cardiac fibroblasts (Figure [S8A](#bph14830-supitem-0001){ref-type="supplementary-material"}). The relative expression of nucleolin in cardiomyocytes is higher than whole heart, freshly isolated cardiac fibroblasts, and cultured cardiac fibroblasts (Figure [3](#bph14830-fig-0003){ref-type="fig"}a).

The expression of nucleolin protein was determined in isolated cardiac myocytes and fibroblasts by immunoblot (Figure [3](#bph14830-fig-0003){ref-type="fig"}b). In cardiomyocytes, two clear bands were detected at 75--80 kDa and \~110 kDa, whereas three bands between \~90 and \~110 kDa were detected in cardiac fibroblasts. By subcellular protein fractionation, the predicted \~76‐kDa band detected by immunoblotting against nucleolin was abundant in the membrane of cardiomyocytes, (Figure [3](#bph14830-fig-0003){ref-type="fig"}c) against both nuclear and cytosolic protein fractions. Immunocytochemistry showed striated nucleolin staining in non‐permeabilized cardiomyocytes (Figure [3](#bph14830-fig-0003){ref-type="fig"}d). Overexpression of nucleolin in HEK293 cells confirmed the specificity of the antibody (Figure [3](#bph14830-fig-0003){ref-type="fig"}b). Confocal image of HEK293 cells indicates that the main site for the overexpression was in the nucleolus in these cells (Figure [S8D,E](#bph14830-supitem-0001){ref-type="supplementary-material"}). However, nucleolin also appear in the membrane fractions of HEK293 cells as shown by western blot (Figure [S5I](#bph14830-supitem-0001){ref-type="supplementary-material"}).

Expression of the \~100‐kDa nucleolin band was the same in nuclear, cytosolic, and membrane fractions (Figure [S8B](#bph14830-supitem-0001){ref-type="supplementary-material"}). The purity of the subcellular fractions (Figure [S9](#bph14830-supitem-0001){ref-type="supplementary-material"}) was confirmed by immunoblotting against the <https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=180#945>; membrane), GAPDH (cytosol), and <https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2616>; nucleus).

3.5. Mitochondrial DNA binds 10‐fold more strongly to nucleolin than nuclear DNA {#bph14830-sec-0030}
--------------------------------------------------------------------------------

Microscale themophoresis (MST) profiles for nucleolin mixed with mtDNA or nDNA were collected using an NT.115 MST instrument (Figure [4](#bph14830-fig-0004){ref-type="fig"}). The Δ*F* ~norm~ signal was calculated for 5 s of thermophoresis, and a binding curve was fitted to each profile. The signal from the labelled protein at 50 nM is at the lower end of the sensitivity of the NT.115 instrument, but at the same, the protein concentration is too high compared with the apparent *K* ~D~ values to perform a valid curve fitting and calculation of *K* ~D~. As the interaction between nucleolin and DNA is so strong, no exact (*K* ~D~) could be calculated from the fitted binding curve. However, a range of 1--10 nM and 10--100 nM can be inferred from the binding curves for mtDNA and nDNA, respectively. This MST experiment shows that nucleolin interacts directly with mtDNA and that it binds to mtDNA about one order of magnitude more strongly than to nDNA.

![Microscale thermophoresis binding curves for nucleolin binding to mtDNA (green) and nDNA (blue). The binding is shown as fluorescence response normalized to binding fraction as a function of DNA concentration and with binding curves for mtDNA and nDNA. The concentration of the DNA is calculated using a molecular mass of DNA fragments corresponding to 300 base pairs](BPH-176-4360-g004){#bph14830-fig-0004}

3.6. Nucleolin inhibition reduced uptake of CpG DNA in cardiomyocytes and fibroblasts {#bph14830-sec-0031}
-------------------------------------------------------------------------------------

As nucleolin is expressed in the membranes of cardiomyocytes, we investigated the effect of nucleolin inhibition on the uptake of fluorescent CpG in cardiac cells. Although not quantified, the uptake of fluorescent CpG appeared higher in cardiac fibroblasts than cardiac myocytes. In isolated cardiomyocytes, the uptake of fluorescent CpG DNA was reduced when the cells were incubated in the presence of the nucleolin inhibitor midkine (Figure [5](#bph14830-fig-0005){ref-type="fig"}), and CpG was detected intracellularly in cardiomyocytes by confocal microscopy. Midkine also inhibited the uptake of fluorescent CpG in cardiac fibroblasts (Figure [5](#bph14830-fig-0005){ref-type="fig"}). Representative laser scanning confocal micrographs showed attenuation of the intracellular punctuate pattern of fluorescent CpG uptake by midkine treatment. Midkine did not influence cardiomyocyte viability or morphology (Figure [S10](#bph14830-supitem-0001){ref-type="supplementary-material"}).

![Nucleolin inhibition reduces uptake of CpG DNA in cardiac cells. Cardiomyocytes were incubated overnight with no treatment (Con), 20 μg·ml^−1^ fluorescent CpG (CpG), or fluorescent CpG and 200‐nM midkine (CpG + Mid). (a) Uptake of fluorescent CpG was evaluated by automated fluorescent microscopy (averaging 3,400 cells from each animal, *n* = 5, mean ± *SEM*, normalized to CpG group). (b) The uptake of fluorescent CpG in cardiomyocytes was also evaluated by confocal microscopy. The same experiments were performed for cardiac fibroblasts, and the uptake of CpG was quantified using the same method and normalized to CpG: (c) automated fluorescence microscopy and (d) confocal microscopy. \**P* \< .05, significantly different as indicated; one‐way ANOVA with Tukey multiple comparisons test](BPH-176-4360-g005){#bph14830-fig-0005}

4. DISCUSSION {#bph14830-sec-0032}
=============

We show for the first time that mtDNA rapidly induced an innate immune response in cardiomyocytes exposed to non‐lethal H/R and that mtDNA and H/R act in concert to induce NF‐κB activity via a TLR9‐dependent mechanism. We showed that nucleolin binds more strongly to mtDNA than to nDNA, although it binds both with high affinity. Nucleolin is highly expressed in the heart and is found in the cell membrane of cardiomyocytes. Blocking nucleolin reduced expression of IL‐1β and TNF‐α and release of IL‐6 from cardiomyocytes. The present investigation provides the first evidence of mtDNA and nucleolin binding and that nucleolin may facilitate uptake of immunogenic DNA in primary cultures of cardiac cells.

mtDNA has been shown to be a DAMP in patients with rheumatoid arthritis (Hajizadeh, DeGroot, TeKoppele, Tarkowski, & Collins, [2003](#bph14830-bib-0021){ref-type="ref"}) and trauma (Zhang et al., [2010](#bph14830-bib-0053){ref-type="ref"}). We have shown that mtDNA is released into the circulation after reperfusion in patients with STEMI (Bliksoen et al., [2012](#bph14830-bib-0007){ref-type="ref"}). Our recent findings showed that mtDNA was internalized, activated an NF‐κB response, and reduced viability of mouse cardiomyocytes after exposure to mtDNA (Bliksoen et al., [2016](#bph14830-bib-0008){ref-type="ref"}). To create a physiologically relevant in vitro model of the metabolic stress of the post‐ischaemic extracellular milieu, cardiomyocytes were exposed to mtDNA and H/R. Indeed, these stressors appeared to act in concert to induce pro‐inflammatory genes without involvement of specialized immune cells. There was no such effect from nDNA, suggesting that structural or sequence specific properties of the different DNAs guide immunogenicity. It has been suggested that mtDNA resembles bacterial DNA, which contains pro‐inflammatory unmethylated CpG motifs (Collins et al., [2004](#bph14830-bib-0011){ref-type="ref"}; Pollack et al., [1984](#bph14830-bib-0038){ref-type="ref"}) capable of inducing sterile inflammation (Oka et al., [2012](#bph14830-bib-0037){ref-type="ref"}; Zhang et al., [2010](#bph14830-bib-0053){ref-type="ref"}). In the acute setting of H/R or mtDNA alone, we saw no inflammatory response. H/R and mtDNA appear to signal through both the NF‐κB and IFN regulatory factor pathways (Kawai & Akira, [2009](#bph14830-bib-0030){ref-type="ref"}), with stronger activation of the former. Moreover, extracellular stressors can also activate the <https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1770>‐inflammasome leading to increased expression of IL‐1β (Weber, Wasiliew, & Kracht, [2010](#bph14830-bib-0051){ref-type="ref"}). The reduced expression of IL‐1β and TNF‐α and reduced IL‐6 release after nucleolin inhibition indicate that the immune response from mtDNA in cardiomyocytes was blocked at an early stage in the inflammatory pathway. To further investigate the different cellular responses to the mtDNA or nDNA in the H/R‐TLR9 setting, we used a reporter system to study the role of TLR9 in synergistic NF‐κB activation by H/R and extracellular DNA.

In HEK293 cells, mtDNA but not nDNA induced a NF‐κB response. In addition, H/R was a strong inducer of NF‐κB activity. Hypoxia has been shown to induce NF‐κB activity in the heart (Fitzpatrick et al., [2011](#bph14830-bib-0016){ref-type="ref"}), but to our knowledge, this is the first demonstration of synergistic NF‐κB activation with concurrent exposure to H/R and extracellular DNA. CpG B is thought to be a more potent inducer of NF‐κB signalling than CpG A, whose canonical role is stimulation of the IFN regulatory factor pathway culminating in the release of type 1 IFN (Verthelyi, Ishii, Gursel, Takeshita, & Klinman, [2001](#bph14830-bib-0049){ref-type="ref"}). CpG C is a stimulator of both pathways. CpG A induced TLR9‐dependent NF‐κB activity as potently as CpG B during H/R. The synergistic effect of DNA ligands and H/R should be also considered in other assays when studying inflammatory responses in cardiomyocytes.

Endocytosis did not appear to be involved in internalization of extracellular DNA in cardiomyocytes. Neither cytochalasin D, which depolymerizes filamentous actin to inhibit micropinocytosis (Dutta & Donaldson, [2012](#bph14830-bib-0014){ref-type="ref"}), nor the dynamin GTPase blocker dynasore, which inhibits clathrin‐mediated endocytosis (Dutta & Donaldson, [2012](#bph14830-bib-0014){ref-type="ref"}), inhibited the uptake of CpG into cardiomyocytes. The efficacy of both inhibitors was validated as they inhibited the uptake of fluorescently labelled dextran in cardiomyocytes. These observations suggested a nucleic acid‐specific uptake mechanism. Nucleolin is abundant in the heart and shows higher expression at both mRNA and protein levels in cardiomyocytes compared to cardiac fibroblasts. Nucleolin is abundant in the nucleolus where it is important for control of cell proliferation and shuttling of pre‐RNAs from the nucleus to the cytoplasm (Medina et al., [2010](#bph14830-bib-0033){ref-type="ref"}; Tajrishi et al., [2011](#bph14830-bib-0046){ref-type="ref"}). We found a strong interaction between nucleolin and mtDNA, 10‐fold stronger than nDNA. To our knowledge, this is the first report that extracellular DNA can bind to nucleolin and indicate that nucleolin can transport extracellular DNA taken up by cells.

To identify the subcellular localization of the protein, we investigated pure subcellular fractions and showed by immunoblotting the presence of nucleolin on the membrane of cardiomyocytes, a finding also confirmed by immunocytochemistry. Nucleolin mRNA and protein are expressed in the hearts of rats and mice (Jiang et al., [2013](#bph14830-bib-0027){ref-type="ref"}). In that study, Jiang et al. suggested a protective role for nucleolin mediated through <https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1441>. In rats, nucleolin mRNA expression is reduced by about 50% 6 hr after in vivo ischaemia--reperfusion (Jiang et al., [2013](#bph14830-bib-0027){ref-type="ref"}). They reported a nucleolin protein band of about 110 kDa, which appears to be cleaved during in vivo ischaemia--reperfusion, as the intensity diminishes simultaneously with the appearance of a 80‐kDa band. Species differences and different primary antibodies might account for the relatively high abundance of the \~76‐kDa nucleolin band in our study.

Having established that nucleolin was expressed in the cardiomyocyte membrane, we investigated its involvement in internalization of immunogenic DNA. The cell‐surface nucleolin blocker midkine (Hovanessian, [2006](#bph14830-bib-0025){ref-type="ref"}; Said et al., [2002](#bph14830-bib-0041){ref-type="ref"}) reduced the uptake of fluorescent CpG DNA in both cardiomyocytes and cardiac fibroblasts. At the concentration used, midkine did not influence morphology or viability of cardiac cells. It is important to note that midkine is a dual‐function cytokine implicated in progression of inflammatory disease, such as experimental autoimmune encephalomyelitis (Wang et al., [2008](#bph14830-bib-0050){ref-type="ref"}), but with protective effects in both myocardial infarction (Horiba et al., [2006](#bph14830-bib-0024){ref-type="ref"}) and in post‐infarction heart failure (Fukui et al., [2008](#bph14830-bib-0019){ref-type="ref"}; Takenaka et al., [2009](#bph14830-bib-0047){ref-type="ref"}). Midkine has also been suggested to have therapeutic potential in cardiovascular disease in general (Kadomatsu et al., [2014](#bph14830-bib-0029){ref-type="ref"}). While the beneficial role of midkine in acute myocardial infarction is fairly well established, its role in heart failure is still debated (Woulfe & Sucharov, [2017](#bph14830-bib-0052){ref-type="ref"}). It is tempting to speculate that one of the protective roles of midkine in the acute setting might be via our novel finding of reduced uptake of immunogenic mtDNA in cells. The function of nucleolin in the heart is poorly understood, but it is up‐regulated at the mRNA and protein level in human heart failure (Rosello‐Lleti et al., [2012](#bph14830-bib-0040){ref-type="ref"}). Nucleolin is expressed on the cell surface of many cell types (Fujiki, Watanabe, & Suganuma, [2014](#bph14830-bib-0018){ref-type="ref"}), and several lines of evidence underlie the hypothesis that cell‐surface nucleolin is important for internalization of DAMPs, including immunogenic DNA. Among others, nucleolin is important for the attachment of HIV‐1 to the cell surface of CD4+ T cells (Said et al., [2002](#bph14830-bib-0041){ref-type="ref"}) and is required for internalization of human parainfluenza virus type 3 to airway epithelial cells (Bose, Basu, & Banerjee, [2004](#bph14830-bib-0009){ref-type="ref"}). Cell‐surface nucleolin is the receptor for a 26‐mer DNA oligonucleotide (Soundararajan et al., [2009](#bph14830-bib-0045){ref-type="ref"}), which is around the same size as the commercial CpGs used in this study. Furthermore, nucleolin mediates the uptake of \~8,000‐kDa DNA nanoparticles (Chen et al., [2008](#bph14830-bib-0010){ref-type="ref"}), which are slightly larger than CpG DNA (Ribes et al., [2014](#bph14830-bib-0039){ref-type="ref"}). Collectively, previous reports create a plausible rationale for the importance of cell‐surface nucleolin for internalization of immunogenic DNA.

In conclusion, mtDNA, but not nDNA, trigger an inflammatory response during H/R in cardiomyocytes. H/R and CpG synergistically activate NF‐κB via TLR9 in HEK293 cells. Nucleolin is highly expressed in cardiomyocytes, can bind mtDNA, and is mainly expressed on cardiomyocyte membranes. Blocking nucleolin in cardiomyocytes reduces uptake of immunogenic DNA and reduces inflammation. We propose that nucleolin might be a novel target for modulating sterile inflammation after acute myocardial infarction.

AUTHOR CONTRIBUTIONS {#bph14830-sec-0034}
====================

L.H.M. designed the study, and L.H.M. and M.K.T. performed experiments and wrote the first draft of the manuscript. A.B., C.H.M., and Y.L. performed experiments, analysed data, and edited the manuscript. G.V., J.V., and K.O.S. designed the study and analysed data, and J.V. and K.O.S. finalized writing of the manuscript. All co‐authors (except G.V.) have approved the manuscript.

CONFLICT OF INTEREST {#bph14830-sec-0035}
====================

The authors declare no conflicts of interest.

DECLARATION OF TRANSPARENCY AND SCIENTIFIC RIGOUR {#bph14830-sec-0036}
=================================================

This Declaration acknowledges that this paper adheres to the principles for transparent reporting and scientific rigour of preclinical research as stated in the *BJP* guidelines for <https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14207>, <https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14208>, and <https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/bph.14206>, and as recommended by funding agencies, publishers and other organisations engaged with supporting research.

Supporting information
======================

###### 

**Figure S1.** In control experiments, cardiomyocytes and fibroblasts were isolated from six mouse hearts and snap frozen in liquid nitrogen. Their expression of cardiac cell type specific genes was compared to cardiac fibroblasts cultured for three passages and whole mouse hearts. Troponin I is a cardiomyocyte specific marker, α‐Smooth muscle actin (α‐SMA) is a smooth muscle cell marker, Vimentin is a marker of fibroblasts and CD31 a marker of endothelial cells. Data represents mean ± SEM and Kruskal‐Wallis test with Dunn\'s multiple comparisons test was used (\**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001).

**Figure S2.** The relative quantities of mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) in the preparations were evaluated by qPCR using primers for murine MT‐ND‐1 (mitochondrially encoded NADH dehydrogenase 1) for mtDNA and NDUFV1 (NADH dehydrogenase (ubiquinone) flavoprotein 1) for nDNA. A; ct values for each gene in mitochondrial and nuclear fractions. B; from the equation *DNA content (pg)* = *genome size (bp) / (0.978 × 109)*, the mass mtDNA and nDNA in our typical 20 μg mL^−1^ stimulation was estimated. C: fragmentation of sonicated (+) or non‐sonicated (−) DNA (mtDNA upper gel and nDNA lower gel) was confirmed by 1% agarose gel electrophoresis with a DNA ladder and visualized with SYBR Safe.

**Figure S3.** Panel A: Actual oxygen concentration inside the hypoxia chamber as a function of time by the in‐built oxygen sensor (chamber internal) and a galvanometric hand‐held probe (chamber probe). The latter was also used to measure oxygen concentration in cell‐free medium and we found that medium had to be incubated overnight (\>12 hours) for the concentration of dissolved oxygen in the medium (medium probe) to drop to the level of the hypoxia chamber (0.5%). Data presented as mean ± SEM. Panel B: Oxygen on the plastic surfaces should be washed away to ensure true hypoxia. The oxygen concentration in cell culture dishes that were brought into the hypoxia chamber from ambient O2 was measured. Merely replacing normoxic medium with hypoxic medium (No wash) was insufficient to rapidly reduce dissolved oxygen in the cell culture dish. However, washing the cell culture dish with hypoxic medium (Single wash, 0 min) more than halved the dissolved oxygen compared to no wash and after 20 minutes the dissolved oxygen had fallen to the level of hypoxic medium alone (Single wash, 20 min). Dissolved oxygen was compared to normoxic PBS and medium left overnight in the hypoxia chamber.

**Figure S4.** Cardiac fibroblasts (panel A) and cardiomyocytes (panel B) were exposed to 40 minutes of glucose‐free hypoxia (\<0.5%) followed by two hours of euglycemic reoxygenation and compared to cells exposed to euglycemic normoxia for the entire period with time‐matched medium change. Necrotic cell death was evaluated with Roche\'s Cytotoxicity detection kit (LDH release) and related to 100% cell death in lysed control wells before normalization to normoxic control (100% and dotted lines). Data represent median, inter‐quartile range and 95 % CI. One‐way ANOVA with Tukey post‐test was used, \**p*\<0.05. Panel C: In pilot experiments, longer duration of hypoxia than 40 minutes caused cell death as evaluated by LDH release in murine cardiomyocytes (*n*=5 in H/R group, *n* = 8 in normoxia group), data presented as mean ± SEM. Panel D: Quantitative real‐time PCR on isolated adult C57BL/6 murine cardiomyocytes (*n* = 4 individuals) exposed to 40 minutes of non‐lethal glucose‐free hypoxia (\<0.5% O2) and two hours of reoxygenation (H/R) or time‐matched normoxic conditions with medium change (normoxia). Panel E and F: Control experiments showing cytokine expression in cardiomyocytes after treatment of the nucleolin blockers (Midkine 200 nM and AS1411 10 μg ml^−1^) in normoxic controls and after hypoxia/reoxygenation (*n* = 7). Normoxic (white bars) and hypoxic (black bars) expression of TNFα and IL‐1β after exposure to Midkine or AS1411 alone (n = 7). The data shows relative gene (2‐ΔΔct) expression normalized to the expression of the housekeeping gene Rpl32 calibrated to normoxic control cells. Data presented as mean ± SEM.

**Figure S5.** Hypoxia/reoxygenation (H/R) drives low‐grade TLR9 independent NF‐κB response and CpG‐induced NF‐κB response is TLR9 dependent. Panel A: HEK293 NF‐κB reporter cells with (mTLR9) or without (TLR9null) overexpression of murine TLR9 were exposed to normoxia or H/R (panel B) and stimulation with CpG B or vehicle control. NF‐κB after eight hours in panels A and B are summarized in panel C. D: HEK293 NF‐κB mTLR9 reporter cells were exposed to normoxia or H/R (panel E) and CpG A or B or control. Panel F: HEK293 NF‐κB mTLR9 reporter cells were exposed to normoxia or H/R (panel G) and CpG A with or without chloroquine (Clq, inhibitor of endosomal acidification, 100 ng/mL) or inhibitory CpG (CpGi, 20 μg/mL). Twenty μg/mL CpG A or B were used. The data represents mean ± SEM and *n* = 5 in all group. One‐way ANOVA with Tukey post test was used, and \#*p*\<0.01, \#\#\#*p*\<0.001 vs normoxic control, \*\*\*p\<0.001 between indicated groups. H) TLR9 expression in cellular fractions of HEK293 mTLR9 and TLR9null cells. I) Nucleolin expression in cellular fractions of HEK293 cells.

**Figure S6.** HEK293 TLR9null cells (*n* = 6) exposed to 20 μg/ml mtDNA or 20 μg/ml nDNA. Gene expression of A) IL‐6 and B) TNFα. Data represents mean ± SEM and Kruskal‐Wallis test with Dunn\'s multiple comparisons test was used (\**p*\<0.05, \*\**p*\<0.01, \*\*\**p*\<0.001).

**Figure S7.** A, B) Mouse cardiomyocytes were exposed overnight to 50 uM fluorescently labeled dextran, with or without the endocytosis blockers cytochalasine D (1 or 50 uM) and dynasore (10 and 25 uM). We could successfully reduce uptake of dextrane with 50 uM cytochalasine D. C, D) Blocking endocytosis with cytochalasine D did not reduce uptake of fluorescently labeled CpG.

**Figure S8.** Nucleolin isoforms in subcellular cardiomyocyte fraction (*n* = 3). Subcellular fractionation of cardiomyocyte protein and immunoblotting against nucleolin was performed, for \~76 kDa (panel A) and \~100 kDa bands (panel B) and their ratios were quantified (panel C). Data represents mean ± SEM. D) Confocal images of HEK293 cells transfected with nucleolin attached to GFP and stained with propidium iodide (stains necrotic nuclei) and hoechst. E) Higher magnification shows the nucleolin GFP in the nucleolus. F) Overview of the transfected HEK293 cells.

**Figure S9.** Subcellular fractionation of cardiomyocyte proteins (*n* = 3). The membrane fraction contained 6.4 fold more of the membrane protein NCX1 (panel A) than the nuclear fraction and 11 fold more NCX1 than the cytosolic fraction. The cytosolic fraction contained 2.3 fold more of the cytosolic protein GAPDH (panel B) than the nuclear fraction and 3.0 fold more than the membrane fraction. There was no difference in protein expression of the nuclear protein HDAC2 in the nuclear and cytosolic fractions, but the nuclear fraction contained 5.9 fold more HDAC2 than the membrane fraction (panel C). Data represents mean ± SEM.

**Figure S10.** Cardiomyocytes were exposed overnight to 20 μg/mL CpG DNA and/or 200 nM midkine (Mid) and compared to non‐treated controls. There was no difference in the viability as evaluated by the percentage of PI negative cells (panel A) or morphology as evaluated by the elongation factor of viable cells (the ratio of the maximum length of the cell to the maximum width normal to length). Data represents mean ± SEM, *n* = 8. One‐way ANOVA where\< 0.05 was considered significant.

**Table S1.** qPCR primer sequences for cardiac cell experiments. All qPCR primers were ordered for SYBR Green chemistry from Eurofins (Hamburg, Germany) at final concentrations at 10 pM.

**Table S2.** Nucleotide sequence for the aptamer and nucleolin inhibitor AS1411.

**Table S3.** qPCR primer sequences for HEK293 cell experiments

###### 

Click here for additional data file.
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[^1]: Professor Valen passed away September 26, 2014.
